{"article_title": "Illinois Health and Science buys radiopharmaceutical manufacturer IBA Molecular", "article_keywords": ["science", "memorial", "decatur", "iba", "hospital", "buys", "according", "illinois", "health", "radiopharmaceutical", "molecular", "company", "manufacturer"], "article_url": "http://www.healthcarefinancenews.com/news/illinois-health-and-science-buys-radiopharmaceutical-manufacturer-iba-molecular", "article_text": "Photo of Decatur Memorial Hospital from Facebook\n\nDecatur Memorial Hospital operator Illinois Health and Science is acquiring, for an undisclosed price, radiopharmaceutical manufacturer IBA Molecular, according to IBAM.\n\nIBA Molecular North America will continue to operate as an independent company headquartered in Dulles, Virginia.\n\n[Also: Tracking 2015 mergers and acquisitions]\n\nThe collaboration will provide a network of accessible supply locations for all medical-use radiopharmaceuticals, according the company.\n\nThe move boosts Illinois Health and Science\u2019s development of a new, high-capacity radiopharmaceutical production facility in Indianapolis, through its company Zevacor Molecular.\n\nIllinois Health and Science is the parent company of Decatur Memorial Hospital, a regional not-for-profit hospital with over $900 million in revenue.\n\nTwitter: @SusanMorseHFN", "article_metadata": {"og": {"url": "http://www.healthcarefinancenews.com/news/illinois-health-and-science-buys-radiopharmaceutical-manufacturer-iba-molecular", "image": "http://www.healthcarefinancenews.com/sites/healthcarefinancenews.com/files/Decatur%20Memorial%20Hospital-Facebook-feature.png", "site_name": "Healthcare Finance News", "description": "The move boosts Illinois Health and Science\u2019s development of a new, high-capacity radiopharmaceutical production facility in Indianapolis.", "title": "Illinois Health and Science buys  radiopharmaceutical manufacturer IBA Molecular"}, "twitter": {"site": "@HC_Finance", "image": {"src": "http://www.healthcarefinancenews.com/sites/healthcarefinancenews.com/files/Decatur%20Memorial%20Hospital-Facebook-feature.png"}, "description": "The move boosts Illinois Health and Science\u2019s development of a new, high-capacity radiopharmaceutical production facility in Indianapolis.", "card": "summary_large_image", "title": "Illinois Health and Science buys  radiopharmaceutical manufacturer IBA Molecular"}, "generator": "Drupal 7 (http://drupal.org)", "description": "Decatur Memorial Hospital operator Illinois Health and Science is acquiring, for an undisclosed price, radiopharmaceutical manufacturer IBA Molecular, according to IBAM.&#13; IBA Molecular North America will continue to operate as an independent company headquartered in Dulles, Virginia.&#13; [Also: Tracking 2015 mergers and acquisitions]", "viewport": "width=device-width; initial-scale=1.0; maximum-scale=1.0; user-scalable=no"}, "article_summary": "Photo of Decatur Memorial Hospital from FacebookDecatur Memorial Hospital operator Illinois Health and Science is acquiring, for an undisclosed price, radiopharmaceutical manufacturer IBA Molecular, according to IBAM.\nIllinois Health and Science is the parent company of Decatur Memorial Hospital, a regional not-for-profit hospital with over $900 million in revenue.\nThe move boosts Illinois Health and Science\u2019s development of a new, high-capacity radiopharmaceutical production facility in Indianapolis, through its company Zevacor Molecular.\nIBA Molecular North America will continue to operate as an independent company headquartered in Dulles, Virginia.\n[Also: Tracking 2015 mergers and acquisitions]The collaboration will provide a network of accessible supply locations for all medical-use radiopharmaceuticals, according the company."}